About Us

Mission and Values

At tonic bioventures, we leverage early regulatory and clinical development expertise to identify, validate and advance breakthrough drugs and medical technologies through innovative companies that can transform the lives of patients, while reducing healthcare costs and time to market.

Core to our values is diversity, which fuels innovation and fosters growth.

Our Approach

By starting with big ideas and fostering collaboration with a team of experts and advisors in science, medicine, business operations and strategy, we set out to do more than funding startups – we provide the tonic to build sustainable, innovative companies that can transform the lives of patients.

Our 5-Step Approach

We Invest in Life Sciences Assets with an Approach that Reduces the Most Common Investment Risks

1.   Discovery

We Identify true innovation from high-impact science and technology

2.  De-Risked

We leverage science and experience to guide clinical translation and regulatory approval

3.  Shape

We create the right business model, defined by and managed by an experienced Operating Partner

4.  Strengthen

We efficiently mature technology utilizing on demand services

5.  Exit

Provide ready access to corporate strategies creating multiple liquidity opportunities

Our portfolio spans a spectrum of investment approaches from asset-centric product plays to big science product platforms.

Entrepreneurial Process is our How

ONE

We harness science to navigate transformational outcomes in healthcare that benefits the patients we serve.

TWO

We leverage CSSi LifeSciences CRO for leading scientific, regulatory and managerial talent for our portfolio companies to help them create best in class teams.

THREE

We guide our venture operators in the exploration and validation of proprietary platform opportunities across multiple therapeutic areas.

FOUR

We create and provide each NewCo with an ecosystem and the resources that focuses on accelerating new product development, while mitigating risks, time and costs.

FIVE

Grow each NewCo and exit to strategic partners or attract investors to grow and transform NewCo.

SIX

As primary resource providers and principal owners of NewCo’s we take full responsibility for their success.

We aim to deliver extraordinary returns by creating the world’s most innovative and valuable life sciences companies.